Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

Go back to Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.23 -0.03 (2.38%)
Previous Close $1.26    52 Week High $6.22 
Open $1.24    52 Week Low $2.74 
Day High $1.27    P/E N/A 
Day Low $1.23    EPS $-0.21 
Volume 103,977